Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition in Patients With Change From Botulinum Toxin Type A

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02175719

Enrollment

150

Registered

2014-06-26

Start date

2013-04-16

Completion date

2017-12-31

Last updated

2018-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Dystonia

Keywords

Torticollis, rimabotulinumtoxinB

Brief summary

Investigation of the clinical condition in patients with cervical dystonia by Toronto Western Spasmodic Torticollis Scale (TWSTRS)

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

Patients with cervical dystonia who was treated by botulinum toxin type A in the past. Patients who was enrolled in NB01S and was evaluated by TWSTRS at the first injection of NerBloc.

Design outcomes

Primary

Measure	Time frame	Description
Whole improvement level	Up to 1 year	Toronto Western Spasmodic Torticollis Scale (TWSTRS)

Countries

Japan

Outcome results